Brief: Abionyx Pharma Announces Patient Temporary Authorization For Use (ATUn) For CER-001 In France
Jan 8 (Reuters) - Abionyx Pharma SA ABNX.PA :
* ABIONYX PHARMA SA ANNOUNCES A NAMED PATIENT TEMPORARY
AUTHORIZATION FOR USE (ATUN) FOR CER-001 IN FRANCE
* ABIONYX PHARMA HAS COMMITTED TO SUPPLY PRODUCT FREE OF
CHARGE
OVER A PERIOD OF THREE MONTHS
Source text for Eikon: ID:nBwf0wvna
Further company coverage: ABNX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Abionyx Pharma SA
See all newsBrief: ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership
France's ABIONYX Pharma H1 net loss widens as financial expenses rise
Brief: ABIONYX Pharma H1 EBIT EUR -2.27 Million
Abionyx jumps as Stifel starts coverage with 'buy'
Cardiovascular drug developer ABIONYX Pharma's H1 revenue falls